151 related articles for article (PubMed ID: 32705908)
1. Clinical and prognostic role of interim 18F-FDG PET/CT in elderly Hodgkin lymphoma: a dual-center experience.
Albano D; Mazzoletti A; Zilioli VR; Muzi C; Crucitti L; Tucci A; Pagani C; Re A; Rossetti C; Giubbini R; Bertagna F
Leuk Lymphoma; 2020 Dec; 61(13):3209-3216. PubMed ID: 32705908
[TBL] [Abstract][Full Text] [Related]
2. CT-based texture analysis potentially provides prognostic information complementary to interim fdg-pet for patients with hodgkin's and aggressive non-hodgkin's lymphomas.
Ganeshan B; Miles KA; Babikir S; Shortman R; Afaq A; Ardeshna KM; Groves AM; Kayani I
Eur Radiol; 2017 Mar; 27(3):1012-1020. PubMed ID: 27380902
[TBL] [Abstract][Full Text] [Related]
3. Interim PET-CT-guided therapy in elderly patients with Hodgkin lymphoma-a retrospective national multi-center study.
Bentur OS; Dann EJ; Paran E; Lavie D; Nachmias B; Ron Y; Dally N; Gutwein O; Herishanu Y; Sarid N; Avivi I; Perry C
Ann Hematol; 2019 Jul; 98(7):1665-1674. PubMed ID: 31104090
[TBL] [Abstract][Full Text] [Related]
4. Interim FDG-PET/CT for therapy monitoring and prognostication in Hodgkin's Lymphoma.
Al-Ibraheem A; Anwer F; Juweid ME; Shagera QA; Khalaf AN; Obeidat S; Mansour A; Ma'koseh M; Halahleh K; Jaradat I; Almasri N; Mansour A
Sci Rep; 2022 Oct; 12(1):17702. PubMed ID: 36271128
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of baseline 18F-FDG PET/CT metabolic parameters in elderly HL: a two-center experience in 123 patients.
Albano D; Mazzoletti A; Spallino M; Muzi C; Zilioli VR; Pagani C; Tucci A; Rossetti C; Giubbini R; Bertagna F
Ann Hematol; 2020 Jun; 99(6):1321-1330. PubMed ID: 32333153
[TBL] [Abstract][Full Text] [Related]
6. Interim FDG-PET/CT for Response Assessment of Lymphoma.
Zeman MN; Akin EA; Merryman RW; Jacene HA
Semin Nucl Med; 2023 May; 53(3):371-388. PubMed ID: 36376131
[TBL] [Abstract][Full Text] [Related]
7. Impact of baseline and interim quantitative PET parameters on outcomes of classical Hodgkin Lymphoma.
Santos FM; Marin JFG; Lima MS; Silva-Junior WF; Alves LBO; Moreira FR; Velasques RD; Atanazio MJ; Maia ACA; Buchpiguel CA; Buccheri V; Rocha V
Ann Hematol; 2024 Jan; 103(1):175-183. PubMed ID: 37796339
[TBL] [Abstract][Full Text] [Related]
8. Paediatric and adolescent Hodgkin lymphoma: information derived from diffuse organ uptake of 18 F-fluorodeoxyglucose on pre-treatment and on interim PET/CT.
Jorgov L; Montravers F; Balogova S; Ragu C; Pacquement H; Leblanc T; Abbou S; Ducou-Lepointe H; Landman-Parker J; Talbot JN
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1220-30. PubMed ID: 26660144
[TBL] [Abstract][Full Text] [Related]
9. Metabolic behavior and prognostic value of early and end of treatment 18F-FDG PET/CT in adult Burkitt's lymphoma: the role of Deauville and IHP criteria.
Albano D; Bosio G; Re A; Pagani C; Giubbini R; Bertagna F
Leuk Lymphoma; 2019 Feb; 60(2):326-333. PubMed ID: 29966473
[TBL] [Abstract][Full Text] [Related]
10. 18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma.
Kahraman D; Theurich S; Rothe A; Kuhnert G; Sasse S; Scheid C; Dietlein M; Drzezga A; von Bergwelt-Baildon M; Kobe C
Leuk Lymphoma; 2014 Apr; 55(4):811-6. PubMed ID: 23805904
[TBL] [Abstract][Full Text] [Related]
11. Prognostic value of imaging markers from 18FDG-PET/CT in paediatric patients with Hodgkin lymphoma.
Rodríguez Taroco MG; Cuña EG; Pages C; Schelotto M; González-Sprinberg GA; Castillo LA; Alonso O
Nucl Med Commun; 2021 Mar; 42(3):306-314. PubMed ID: 33306628
[TBL] [Abstract][Full Text] [Related]
12. Interim PET/CT based on visual and semiquantitative analysis predicts survival in patients with diffuse large B-cell lymphoma.
Li X; Sun X; Li J; Liu Z; Mi M; Zhu F; Wu G; Lan X; Zhang L
Cancer Med; 2019 Sep; 8(11):5012-5022. PubMed ID: 31293092
[TBL] [Abstract][Full Text] [Related]
13. Optimisation of metabolic criteria in the prognostic assessment in patients with lymphoma. A multicentre study.
Del Puig Cózar-Santiago M; García-Garzón JR; Moragas-Freixa M; Soler-Peter M; Bassa Massanas P; Sánchez-Delgado M; Sanchez-Jurado R; Aguilar-Barrios JE; Sanz-Llorens R; Ferrer-Rebolleda J
Rev Esp Med Nucl Imagen Mol; 2017; 36(5):304-311. PubMed ID: 28483373
[TBL] [Abstract][Full Text] [Related]
14. [Prognostic value of 18F-FDG PET-CT in Hodgkin lymphoma].
Ying Z; Wang X; Song Y; Zheng W; Wang X; Xie Y; Lin N; Tu M; Ping L; Liu W; Deng L; Zhang C; Yang Z; Zhu J
Zhonghua Xue Ye Xue Za Zhi; 2014 Apr; 35(4):325-7. PubMed ID: 24759021
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of pretreatment 18F-FDG PET/CT in primary brain lymphoma.
Albano D; Bertoli M; Battistotti M; Rodella C; Statuto M; Giubbini R; Bertagna F
Ann Nucl Med; 2018 Oct; 32(8):532-541. PubMed ID: 29982990
[TBL] [Abstract][Full Text] [Related]
16. Interim FDG
Duarte S; Roque A; Saraiva T; Afonso C; Marques BA; Lima CB; Neves D; Lai AC; Costa G; Cipriano A; Geraldes C; Ruzickova L; Carda JP; Gomes M
Clin Lymphoma Myeloma Leuk; 2023 Feb; 23(2):e107-e116. PubMed ID: 36567213
[TBL] [Abstract][Full Text] [Related]
17. The Prognostic Utility of
Li C; Yu H; Chen X; Han S; Peng S; Lei T; Yang H
Front Oncol; 2022; 12():772773. PubMed ID: 35677166
[TBL] [Abstract][Full Text] [Related]
18. Concomitant semi-quantitative and visual analysis improves the predictive value on treatment outcome of interim 18F-fluorodeoxyglucose/positron-emission tomography in advanced Hodgkin lymphoma.
Biggi A; Bergesio F; Chauvie S; Bianchi A; Menga M; Fallanca F; Hutchings M; Gregianin M; Meignan M; Gallamini A
Q J Nucl Med Mol Imaging; 2021 Dec; 65(4):410-415. PubMed ID: 28750493
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Reliability of Interim PET/CT in the Hodgkin Lymphoma.
Eren R; Gündoğan C; Aslan C; Koç A; Doğu MH; Altındal Ş; Yokuş O; Suyanı E; Çermik TF
Curr Med Imaging Rev; 2020; 16(1):59-64. PubMed ID: 31989894
[TBL] [Abstract][Full Text] [Related]
20. Intratumor Heterogeneity Assessed by
Lue KH; Wu YF; Liu SH; Hsieh TC; Chuang KS; Lin HH; Chen YH
Acad Radiol; 2020 Aug; 27(8):e183-e192. PubMed ID: 31761665
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]